Catalyst Wire Dossier Catalyst Wire Dossier

R932348 Eye Drops

R932348 · Rigel Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R932348 Eye Drops, covering 2014-08-04 to 2014-08-04. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease [Phase 1]

See pricing